Principal component analysis of metabolomes found distinct metabolic profiles in normal brain (cortex and normal contralateral cerebellum) compared to MYC-amplified medulloblastoma D425MED and MED211 orthotopic tumors (Figure 1A). This evidence concerns the gene MYC and medulloblastoma.